Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation.
Saved in:
| Title: | Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation. |
|---|---|
| Authors: | Gopal K; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Karwi QG; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Tabatabaei Dakhili SA; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Wagg CS; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Zhang L; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Sun Q; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Saed CT; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Panidarapu S; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Perfetti R; Applied Therapeutics, New York, NY, USA., Ramasamy R; Diabetes Research Program, New York University Grossman Medical Center, New York, NY, USA., Ussher JR; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Lopaschuk GD; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada. gary.lopaschuk@ualberta.ca. |
| Source: | Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Mar 28; Vol. 22 (1), pp. 73. Date of Electronic Publication: 2023 Mar 28. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1475-2840 |
|---|---|
| DOI: | 10.1186/s12933-023-01811-w |
